ALLYSON MARTIN: Open Payments
NPI 1528272069 · REDDING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$529 in 27 payments from 7 companies in 2025. Trend: 2023 $851 · 2024 $722 · 2025 $529
Food & beverage: $529
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $174 |
| Novartis Pharmaceuticals Corporation | 7 | $137 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 12 | $111 |
| Amgen Inc. | 2 | $46 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Boston Scientific Corporation | 1 | $22 |
| PFIZER INC. | 1 | $14 |
Products named: LEQVIO, LifeVest, CARDIOMEMS, REPATHA, ASSURITY, GALLANT, VERQUVO, WATCHMAN FLX.
Industry payments across CA — which companies pay providers there.
